Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy

This study has been completed.
Information provided by (Responsible Party):
DBV Technologies Identifier:
First received: July 24, 2010
Last updated: March 22, 2012
Last verified: March 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2012
  Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)